tirzepatide gray market GLP-1 Drugs from the China Clears Eli Lilly's Weight

Tirzepatide (Zepbound) led to about 20% average body weight loss Semaglutide (Wegovy) led to about 14% average body weight loss

Now, with Medicare and potentially Medicaid covering branded GLP-1s, the exclusivity that fueled $500-a-month subscriptions is evaporating

While GIP indeed acts as an incretin in healthy individuals, researchers found an important limitation in patients with type 2 diabetes, GIP loses most of its insulinotropic efficacy (the pancreatic cells become GIP-resistant) ( [32] )

How Ipamorelin and Sermorelin Work Differently This comparison helps clarify why one peptide may be preferred over the other depending on goals